Stocks
ImmunoGen (IMGN) EV/EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -2.68 | -9.26 | -44.0 | -8.61 | -4.63 | 139.1 | ||
| Changes by years, y/y, % | -46% | +245% | +375% | -80% | -46% | -1.4% | |||
ImmunoGen. EV/EBITDA
ImmunoGen. EV/EBITDA, changes, %
ImmunoGen (IMGN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| EV/EBITDA | ? | -3.58 | -390.5 | -316.9 | 67.1 | 66.1 | 139.1 | |
| Changes by years, y/y, % | -23% | +9 179% | +6 751% | -1 259% | -1 530% | |||
| Changes by quarters, q/q, % | -38% | +10 819% | -19% | -121% | -1% | |||
